ILK and lung carcinoma: In the H661 lung cancer cell line, lunasin prevented β1 and β3 subunits from interacting with pFAK, integrin-linked protein kinase (ILK), and kindlin, while further blocking FAK, Akt, and ERK1/2 phosphorylation [94].